Bausch Health director receives 5,789 stock units

The award represents compensation for Board service for the quarter ended September 30, 2026, with each unit carrying a contingent right to one common share.

Rhea-AI Filing Summary

Bausch Health Companies Inc. director Sandra Leung acquired 5,789 restricted share units in lieu of cash compensation for Board service for the quarter ending September 30, 2026. Each unit represents a contingent right to receive one common share. The transaction reports a price of $5.83 per share, and her reported direct position following the transaction was 102,859 shares.

Insider Trade Summary

Grant/Award: 5,789 shares

Grant/Award 1 txn

Insider LEUNG SANDRA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value F1	5,789	$5.83	$34K

Holdings After Transaction: Common Shares, No Par Value — 102,859 shares (Direct)

Footnotes (1)

1. F1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

Key Figures

Restricted share units: 5,789 RSUs Reported price per share: $5.83 per share Direct shares following transaction: 102,859 shares

3 metrics

Restricted share units 5,789 RSUs Issued in lieu of cash compensation for Board service for the quarter ending September 30, 2026

Reported price per share $5.83 per share Reported for the restricted share unit acquisition

Direct shares following transaction 102,859 shares Sandra Leung's reported position following the transaction

Key Terms

Restricted Share Units, contingent right, no par value

3 terms

Restricted Share Units financial

"Reflects Restricted Share Units issued in lieu of cash compensation"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"each representing a contingent right to receive one common share"

no par value technical

"one common share, no par value, of the Issuer"

Shares described as "no par value" are equity securities issued without a fixed face amount written into the corporate charter; their legal capital is not tied to a specific per-share number and the company may record proceeds differently than for par-value shares. This matters to investors because it affects how a company records equity, sets minimum legal capital, and handles bookkeeping for issuances, dividends and splits—similar to buying slices of a pie where the slice has no printed sticker price and market forces determine worth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did BHC director Sandra Leung receive?

Sandra Leung received 5,789 restricted share units in lieu of cash compensation for Board service for the quarter ending September 30, 2026. Each unit represents a contingent right to receive one common share; the transaction reports a price of $5.83 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:28 PM Accepted by SEC EDGAR 10/02/2026 - 04:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEUNG SANDRA

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	09/30/2026		A		5,789(1)	A	$5.83	102,859	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)